These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 872292)

  • 1. The rabbit as an animal model for the activated factor X-antithrombin III-heparin reaction.
    Gitel SN; Wessler S; Medina VM
    Circ Res; 1977 Aug; 41(2):187-91. PubMed ID: 872292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR; Lie M; Abildgaard U
    Haemostasis; 1976; 5(5):265-75. PubMed ID: 1017722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit.
    Amar J; Caranobe C; Sie P; Boneu B
    Br J Haematol; 1990 Sep; 76(1):94-100. PubMed ID: 2223652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-containing oral contraceptive agents. A basis for their thrombogenicity.
    Wessler S; Gitel SN; Wan LS; Pasternack BS
    JAMA; 1976 Nov; 236(19):2179-82. PubMed ID: 989807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of human activated factor X-antithrombin complex by an enzyme-linked differential-antibody immunosorbent assay.
    Jesty J; Morrison SA; Harpel PC
    Anal Biochem; 1984 May; 139(1):158-67. PubMed ID: 6742427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma antithrombin III: a quantitative assay of biological activity.
    Gitel SA; Wessler S
    Thromb Res; 1975 Jul; 7(1):5-16. PubMed ID: 1154342
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
    Ototani N; Kikuchi M; Yosizawa Z
    Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor.
    Yin ET; Wessler S; Stoll PJ
    J Biol Chem; 1971 Jun; 246(11):3712-9. PubMed ID: 4102937
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of continuous low-dose intravenous heparin administered during operation on postoperative measurements of antithrombin III and antifactor Xa.
    Jennings SA; Heather BP; Greenhalgh RM
    Surgery; 1984 Sep; 96(3):550-5. PubMed ID: 6474360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.
    Bauer KA; Goodman TL; Kass BL; Rosenberg RD
    J Clin Invest; 1985 Aug; 76(2):826-36. PubMed ID: 3875633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human factor Xa by various plasma protease inhibitors.
    Ellis V; Scully M; MacGregor I; Kakkar V
    Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin 3, antifactor Xa and heparin.
    Biggs R; Denson KW; Akman N; Borrett R; Hadden M
    Br J Haematol; 1970 Sep; 19(3):283-305. PubMed ID: 5529547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.